2014 Q4 Form 10-K Financial Statement

#000114420415020231 Filed on March 31, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2014 2013 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.530M $14.94M $4.770M
YoY Change -67.92% 146.94% 1123.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $20.00K $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.530M $14.96M $4.770M
YoY Change -67.92% 147.21% 1123.08%
Operating Profit -$14.96M
YoY Change 147.21%
Interest Expense -$50.00K $183.8K -$10.00K
YoY Change 400.0% -44.75% -98.36%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.284M $50.00K
YoY Change -100.0% -24.47%
Pretax Income -$1.580M -$16.24M -$4.950M
YoY Change -68.08% 109.56% 375.96%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.580M -$16.24M -$4.950M
YoY Change -68.08% 109.56% 375.96%
Net Earnings / Revenue
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$0.76 -$8.202M -$2.81
COMMON SHARES
Basic Shares Outstanding 103.3M shares 99.09M shares 90.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.00K $40.00K $140.0K
YoY Change -71.43% -71.43%
Cash & Equivalents $36.10K $143.1K
Short-Term Investments
Other Short-Term Assets $60.00K $60.00K $10.00K
YoY Change 500.0% 500.0% 0.0%
Inventory
Prepaid Expenses $59.01K $5.000K
Receivables
Other Receivables
Total Short-Term Assets $95.11K $100.0K $148.1K
YoY Change -35.78% -33.33% 1547.19%
LONG-TERM ASSETS
Property, Plant & Equipment $3.520M $38.68M $89.35K
YoY Change 3839.31% 9.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $38.68M $38.67M $89.35K
YoY Change 43189.98% 9.7%
TOTAL ASSETS
Total Short-Term Assets $95.11K $100.0K $148.1K
Total Long-Term Assets $38.68M $38.67M $89.35K
Total Assets $38.77M $38.77M $35.40M
YoY Change 9.54% 9.52% 0.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.155M $2.180M $1.139M
YoY Change 89.17% 87.93% 86.3%
Accrued Expenses $710.3K $960.0K $1.385M
YoY Change -48.73% -34.69% -19.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.350M $25.00K
YoY Change -100.0% 683.33% -98.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.484M $5.480M $2.927M
YoY Change 87.35% 87.03% -60.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.090M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $2.090M
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.484M $5.480M $2.927M
Total Long-Term Liabilities $0.00 $0.00 $2.090M
Total Liabilities $5.480M $5.480M $5.020M
YoY Change 9.16% 9.16% -31.79%
SHAREHOLDERS EQUITY
Retained Earnings -$52.07M $35.83M
YoY Change -245.33%
Common Stock $103.7K $91.27K
YoY Change 13.58% 68.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.29M $33.29M $20.38M
YoY Change
Total Liabilities & Shareholders Equity $38.77M $38.77M $35.40M
YoY Change 9.54% 9.52% 0.65%

Cashflow Statement

Concept 2014 Q4 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$1.580M -$16.24M -$4.950M
YoY Change -68.08% 109.56% 375.96%
Depreciation, Depletion And Amortization $10.00K $20.00K $0.00
YoY Change
Cash From Operating Activities -$1.460M -$1.550M -$130.0K
YoY Change 1023.08% 139.17% 1200.0%
INVESTING ACTIVITIES
Capital Expenditures -$780.0K $1.672M $70.00K
YoY Change -1214.29% 7861.64%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $780.0K -$2.400M -$70.00K
YoY Change -1214.29% 2586.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 720.0K 3.850M 330.0K
YoY Change 118.18% 337.28% 3200.0%
NET CHANGE
Cash From Operating Activities -1.460M -1.550M -130.0K
Cash From Investing Activities 780.0K -2.400M -70.00K
Cash From Financing Activities 720.0K 3.850M 330.0K
Net Change In Cash 40.00K -100.0K 130.0K
YoY Change -69.23% -169.93%
FREE CASH FLOW
Cash From Operating Activities -$1.460M -$1.550M -$130.0K
Capital Expenditures -$780.0K $1.672M $70.00K
Free Cash Flow -$680.0K -$3.222M -$200.0K
YoY Change 240.0% 381.55% 1900.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1385251 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
710286 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2926961 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5483591 USD
CY2013Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
10000000 USD
CY2014Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
10000000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
91266 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
103661 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56114271 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75255143 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35396875 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2154512 USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
86143 USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
246273 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143099 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36095 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5000 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59010 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
148099 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
95105 USD
CY2013Q4 smpr Business Acquisition Cost Of Acquired Entity Purchase Prices
BusinessAcquisitionCostOfAcquiredEntityPurchasePrices
35159427 USD
CY2014Q4 smpr Business Acquisition Cost Of Acquired Entity Purchase Prices
BusinessAcquisitionCostOfAcquiredEntityPurchasePrices
35159427 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
21000 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1758818 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
68349 USD
CY2014Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1778532 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
89349 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3537350 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
25000 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
275000 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
175000 USD
CY2013Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
16616 USD
CY2014Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
16616 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1138951 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
35827720 USD
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
52068126 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
20377817 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
23290678 USD
CY2014 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Revenue Recognition and Deferred Revenue</u>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of December 31, 2014, we have recorded no revenues from custom permitted processing toll milling.&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Use of Estimates</u>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&#160;&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91266411 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103660936 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91266411 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103660936 shares
CY2011Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
35000000 shares
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52068126 USD
CY2014Q4 smpr Working Capital Net
WorkingCapitalNet
5388486 USD
CY2014 smpr Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
3790195 USD
CY2012Q1 smpr Lease Liability
LeaseLiability
112500 USD
CY2012Q1 smpr Lease Termination Fee
LeaseTerminationFee
10500 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Interest Acquired1
NoncashOrPartNoncashAcquisitionInterestAcquired1
0.87 pure
CY2011Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2500000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1933345 USD
CY2012Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
40925 USD
CY2013Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1500000 USD
CY2013Q4 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
27000000 shares
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2011Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
31150000 USD
CY2011Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
700000 USD
CY2011Q1 smpr Business Acquisition Purchase Price Allocations Liabilities Assumed
BusinessAcquisitionPurchasePriceAllocationsLiabilitiesAssumed
2500000 USD
CY2011Q1 smpr Business Acquisition Purchase Price Allocations Current Liabilities Accrued Liabilities
BusinessAcquisitionPurchasePriceAllocationsCurrentLiabilitiesAccruedLiabilities
463184 USD
CY2011Q1 smpr Business Acquisitions Cost Of Acquired Entity Purchase Price
BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice
35159427 USD
CY2013 us-gaap Revenues
Revenues
0 USD
CY2014 us-gaap Revenues
Revenues
0 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6050082 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14938972 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17613 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
6050082 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
14956585 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-6050082 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-14956585 USD
CY2013 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5819 USD
CY2014 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6470 USD
CY2013 smpr Loss On Settlement Of Debt
LossOnSettlementOfDebt
1372977 USD
CY2014 smpr Loss On Settlement Of Debt
LossOnSettlementOfDebt
1106487 USD
CY2013 us-gaap Interest Expense
InterestExpense
332665 USD
CY2014 us-gaap Interest Expense
InterestExpense
183804 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1699823 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1283821 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7749905 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16240406 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-7749905 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-16240406 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
64622893 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
99090384 shares
CY2011Q1 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.89
CY2014 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2014Q4 smpr Business Acquisition Purchase Price Allocations Mineral Rights
BusinessAcquisitionPurchasePriceAllocationsMineralRights
24888252 USD
CY2014Q4 smpr Business Acquisition Purchase Price Allocations Plant
BusinessAcquisitionPurchasePriceAllocationsPlant
8062875 USD
CY2014Q4 smpr Business Acquisitionspurchase Price Allocation Land
BusinessAcquisitionspurchasePriceAllocationLand
1760000 USD
CY2014Q4 smpr Business Acquisitions Purchase Price Allocation Natural Resources
BusinessAcquisitionsPurchasePriceAllocationNaturalResources
348300 USD
CY2014Q4 smpr Business Acquisitions Purchase Price Allocation Other Assets
BusinessAcquisitionsPurchasePriceAllocationOtherAssets
100000 USD
CY2014 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2010-11-30
CY2013Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2015-04-10
CY2012Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2160284 USD
CY2013Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
25000 USD
CY2013 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
382650 USD
CY2013 smpr Payment For Expenses
PaymentForExpenses
410411 USD
CY2013 smpr Reclassification Of Short Term Debt To Senior Secured Convertible Promissory Note
ReclassificationOfShortTermDebtToSeniorSecuredConvertiblePromissoryNote
-1958345 USD
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2013Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.05 pure
CY2012 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
20000 shares
CY2012Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1000000 shares
CY2014 smpr Warrant Conversion Rate Amount
WarrantConversionRateAmount
1 USD
CY2013Q3 smpr Convertible Note Tender Offer Statement Amendment Description
ConvertibleNoteTenderOfferStatementAmendmentDescription
The Company filed a Tender Offer Statement on Schedule TO on July 2, 2013. The Company filed several amendments to the Schedule TO: an amendment was filed on July 8, 2013 to extend the expiration date from 11:59 P.M. (Eastern time) on July 25, 2013 to 11:59 P.M. (Eastern time) on July 30, 2013 and revised the Election to Participate; on July 16, 2013 the Company filed an amendment to change the exercise price of the new warrants from $0.25 for the first 60 days following the tender offer and $0.50 thereafter to $0.25 for the first 180 days following the tender offer and $0.50 thereafter; on July 30, 2013 the Company filed an amendment to extend the expiration date from 11:59 P.M. (Eastern time) on July 30, 2013 to 11:59 P.M. (Eastern time) on August 2, 2013; and on July 31, 2013 the Company filed an amendment to incorporate the press release announcing the extension of the expiration date to 11:59 P.M. (Eastern time) on August 2, 2013.
CY2014 smpr Convertible Note Tender Offer Final Statement Description
ConvertibleNoteTenderOfferFinalStatementDescription
The final terms of the Tender Offer included the Company offering to exchange certain of its outstanding unsecured convertible promissory notes issued between January 2, 2011 and November 2, 2011 (the Original Notes or Eligible Notes) and accompanying warrants to purchase common stock (the Original Warrants or Eligible Warrants) for the issuance of restricted common stock for the settlement of the balance of the note (principal and interest as of: June 30, 2013) at $.50/share and the issuance of new warrants to purchase common stock (the New Warrants) equal to the number of shares received under the conversion of the Eligible Note, exercisable for two years with an exercise price of $0.25 for the first 180 days following the tender offer and $0.50 thereafter, with substantially the same terms as the Original Warrants except the New Warrants will contain a call provision that may be exercised at $0.80 if the Companys common stock trades above $0.80 for ten consecutive days and upon the terms and subject to the conditions set forth in the Offer to Exchange, dated July 2, 2013 (the Offer to Exchange) and the Election to Participate (the Election to Participate). The expiration of the tender offer was 11:59 P.M. (Eastern time) on August 2, 2013.
CY2013Q3 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
1724689 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
17807824 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1866930 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
118562 USD
CY2014 smpr Stock Issued During Period Of Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims
3937663 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1268054 USD
CY2013 smpr Stock Issued During Period Value For Conversion Of Notes Payable
StockIssuedDuringPeriodValueForConversionOfNotesPayable
1500000 USD
CY2013 smpr Stock Issued For Exercise Of Warrants Value
StockIssuedForExerciseOfWarrantsValue
497785 USD
CY2013 smpr Share Issued Under Legal Settlement Of Accrued Liabilities Value
ShareIssuedUnderLegalSettlementOfAccruedLiabilitiesValue
1079323 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
3226501 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
881305 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
8206286 USD
CY2013 smpr Share Based Compensation Expense Per Share
ShareBasedCompensationExpensePerShare
0.04
CY2014 smpr Share Based Compensation Expense Per Share
ShareBasedCompensationExpensePerShare
0.08
CY2014 smpr Unrecognized Share Based Compensation Expense
UnrecognizedShareBasedCompensationExpense
703372 USD
CY2014 us-gaap Guarantee Obligations Liquidation Proceeds
GuaranteeObligationsLiquidationProceeds
50000000 USD
CY2014Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
237118 shares
CY2013Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1775138 shares
CY2013Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
57463 shares
CY2013Q4 smpr Warrants Exercised To Purchase Number Of Common Shares
WarrantsExercisedToPurchaseNumberOfCommonShares
100000 shares
CY2011Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
100000 USD
CY2013Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
25000 USD
CY2013Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
25000 USD
CY2013Q4 smpr Aggregate Purchase Price
AggregatePurchasePrice
0.50
CY2013Q4 smpr Aggregate Purchase Price Value
AggregatePurchasePriceValue
493785 USD
CY2014Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
282000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
400000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
27000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.60
CY2012 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.02 pure
CY2014Q3 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0098 pure
CY2012 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y
CY2012 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
500000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
500000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
500000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
500000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
150000 shares
CY2012 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.53 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2014Q3 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2013Q4 smpr Sharebased Compensation Arrangement By Sharebased Payment Award Warrant Outstanding Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantOutstandingIntrinsicValue
13989207 USD
CY2014Q4 smpr Sharebased Compensation Arrangement By Sharebased Payment Award Warrant Outstanding Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantOutstandingIntrinsicValue
5483980 USD
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5471473 USD
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1301875 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0211 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0221 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10438335 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
28500000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
4000000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6187493 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2337000 shares
CY2013 smpr Stock Issued During Period Share Stock Option Exercised
StockIssuedDuringPeriodShareStockOptionExercised
0 shares
CY2014 smpr Stock Issued During Period Share Stock Option Exercised
StockIssuedDuringPeriodShareStockOptionExercised
282000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32750842 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
34131842 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.89
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.71
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.56
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.79
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.60
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.88
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.99
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.27
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.94
CY2013Q4 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedNumber
21750000 shares
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriod
4000000 shares
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
20500000 shares
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedInPeriod
0 shares
CY2014Q4 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedNumber
5250000 shares
CY2013Q4 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageGrantDateFairValue
0.24
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.94
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.24
CY2014 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2014Q4 smpr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsNonvestedWeightedAverageGrantDateFairValue
0.24
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11126875 shares
CY2013 smpr Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
9534345 shares
CY2014 smpr Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
150000 shares
CY2013 smpr Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
4396878 shares
CY2014 smpr Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
1630000 shares
CY2013 smpr Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
2275138 shares
CY2014 smpr Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
7025227 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13989207 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5483980 shares
CY2014Q4 smpr Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
5483980 shares
CY2012Q4 smpr Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
0.63
CY2013 smpr Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.54
CY2014 smpr Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
2.00
CY2013 smpr Class Of Warrant Or Right Cancelled In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCancelledInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.50
CY2014 smpr Class Of Warrant Or Right Cancelled In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCancelledInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
1.00
CY2013 smpr Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.22
CY2014 smpr Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.54
CY2013Q4 smpr Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
0.67
CY2014Q4 smpr Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
0.79
CY2014 smpr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Grants In Period
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGrantsInPeriod
2.00
CY2014 smpr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Cancelled
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsCancelled
1.00
CY2012 smpr Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P1Y8M12D
CY2013 smpr Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P3Y3M18D
CY2014 smpr Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P4Y9M18D
CY2011Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
300000 shares
CY2011Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
564000 USD
CY2011Q2 smpr Professional Fees Payable Per Month
ProfessionalFeesPayablePerMonth
10000 USD
CY2011Q2 smpr Collaborative Arrangement Profit Share Percentage
CollaborativeArrangementProfitSharePercentage
0.1 pure
CY2011Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.88
CY2014Q2 smpr Base Salary
BaseSalary
1000 USD
CY2014Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.23 pure
CY2013Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1500000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2635000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5519000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2635000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5519000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0 pure
CY2013 smpr Effective Income Tax Rate Reconciliation Expiration Of Stock Options
EffectiveIncomeTaxRateReconciliationExpirationOfStockOptions
0 pure
CY2014 smpr Effective Income Tax Rate Reconciliation Expiration Of Stock Options
EffectiveIncomeTaxRateReconciliationExpirationOfStockOptions
0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.34 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.34 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3574000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9093000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3574000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9093000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3574000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9093000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
20785000 USD
CY2014 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
1,000,000 annually
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5519000 USD
CY2014 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><u><font style="FONT-SIZE: 10pt">NOTE 1 &#150; NATURE OF BUSINESS</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Standard Metals Processing, Inc. (formerly Standard Gold Holdings, Inc., Standard Gold, Inc. and Princeton Acquisitions, Inc.) (the &#8220;Company&#8221;) was incorporated in the State of Colorado on July 10, 1985 as a blind pool or blank check company. On September 29, 2009, we completed a share exchange agreement with Hunter Bates Mining Corporation, a Minnesota corporation (&#8220;Hunter Bates&#8221;) and certain of its shareholders, in which Hunter Bates&#8217; shareholders exchanged all of their capital securities into similar capital securities of ours (the &#8220;Hunter Bates Share Exchange&#8221;) and we adopted the business model of Hunter Bates of mineral exploration and mining. Accordingly, the Hunter Bates Share Exchange represented a change in control and Hunter Bates became a wholly owned subsidiary of the Company.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Prior to September 29, 2009, Wits Basin Precious Minerals Inc., a Minnesota corporation and public reporting company quoted on the Pink Sheets under the symbol &#8220;WITM&#8221; (&#8220;Wits Basin&#8221;) was the majority shareholder of Hunter Bates. Hunter Bates was formed in April 2008 to acquire the prior producing gold mine properties (consisting of land, buildings, equipment, mining claims and permits) located in Central City, Colorado, known as the &#8220;Bates-Hunter Mine.&#8221; We had not engaged in any exploration or mining activities at the Bates-Hunter Mine properties and on April 29, 2011, we transferred all of our interests of Hunter Bates back to Wits Basin in order to develop the toll milling business as described below. &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On March 15, 2011, the Company closed a series of transactions, whereby we acquired certain assets of Shea Mining &amp; Milling, LLC (&#8220;Shea Mining&#8221;). The exchange agreement was by and between the Company, Shea Mining, Afignis, LLC, Leslie Lucas Partners, LLC, Wits Basin and Alfred A. Rapetti (the &#8220;Shea Exchange Agreement&#8221;) whereby the Company acquired certain assets from Shea Mining, which assets include those located in Tonopah, Nevada, of land, buildings, a dormant milling facility, abandoned milling equipment, water permits and mine tailings (financed through a note payable assigned to us), mine dumps, a property lease and a contract agreement in exchange for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35,000,000</font> shares of our unregistered shares. The Shea Exchange Agreement did not include any operable toll milling equipment, employees or operational processes and therefore has been accounted for as a purchase of a group of assets. The Company completed the Shea Exchange Agreement to acquire the Shea Mining assets and develop a toll milling services business of precious minerals. Toll milling is a process whereby mined material is crushed and ground into fine particles to ease the extraction of any precious minerals contained therein, such as gold, silver, lead, zinc and copper, and rare earth metals. See Note 3 &#150; Acquisition of Shea Milling and Mining Assets for a detailed discussion.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-SIZE: 10pt">Going Concern</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, assuming we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the year ended December 31, 2014, the Company incurred losses from operations of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">16,240,406</font>. At December 31, 2014, the Company had an accumulated deficit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">52,068,126</font> and a working capital deficit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,388,486</font>. Our ability to continue as a going concern is dependent on our ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the 2014 fiscal year, the Company received net cash proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,790,195</font> from the exercise of warrants. Management believes that private placements of equity capital and/or additional debt financing will be needed to fund our long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. We are continuing to pursue external financing alternatives to improve our working capital position. If the Company is unable to obtain the necessary capital, the Company may have to cease operations.&#160;</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 smpr Convertible Promissory Note Payable Current
ConvertiblePromissoryNotePayableCurrent
2174597 USD
CY2013Q4 smpr Convertible Promissory Note Payable Current
ConvertiblePromissoryNotePayableCurrent
0 USD
CY2014Q4 smpr Convertible Promissory Note Payable Non Current
ConvertiblePromissoryNotePayableNonCurrent
0 USD
CY2013Q4 smpr Convertible Promissory Note Payable Non Current
ConvertiblePromissoryNotePayableNonCurrent
2092097 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
6307 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2014 smpr Stock Issued During Period Value Accrued Expenses
StockIssuedDuringPeriodValueAccruedExpenses
4592500 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
12798786 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4107806 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-959019 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1372977 USD
CY2014 smpr Increase In Convertible Note Payable Through Payment Of Expenses
IncreaseInConvertibleNotePayableThroughPaymentOfExpenses
0 USD
CY2013 smpr Increase In Convertible Note Payable Through Payment Of Expenses
IncreaseInConvertibleNotePayableThroughPaymentOfExpenses
544164 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
54010 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3897 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
795469 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
306405 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
19053 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
766575 USD
CY2014 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
6307 USD
CY2013 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1550701 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-648081 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1671945 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000 USD
CY2014 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
732053 USD
CY2013 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
68349 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2403998 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-89349 USD
CY2014 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25000 USD
CY2013 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2013 smpr Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
497785 USD
CY2014 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
82500 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3847695 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
880435 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-107004 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
143005 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94 USD
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1500000 USD
CY2014 smpr Short Term Notes Payable And Accrued Interest Converted Into Convertible Promissory Notes
ShortTermNotesPayableAndAccruedInterestConvertedIntoConvertiblePromissoryNotes
0 USD
CY2013 smpr Short Term Notes Payable And Accrued Interest Converted Into Convertible Promissory Notes
ShortTermNotesPayableAndAccruedInterestConvertedIntoConvertiblePromissoryNotes
1866930 USD
CY2014 smpr Debt Conversion Converted Instrument Shares Issued Value
DebtConversionConvertedInstrumentSharesIssuedValue
118559 USD
CY2013 smpr Debt Conversion Converted Instrument Shares Issued Value
DebtConversionConvertedInstrumentSharesIssuedValue
0 USD
CY2014 smpr Common Stock Issued For Payment Of Accrued Expenses
CommonStockIssuedForPaymentOfAccruedExpenses
0 USD
CY2013 smpr Common Stock Issued For Payment Of Accrued Expenses
CommonStockIssuedForPaymentOfAccruedExpenses
1079323 USD
CY2014 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1044004 USD
CY2014 smpr Operating Loss Carry Forwards Expiration Period
OperatingLossCarryForwardsExpirationPeriod
2028
CY2011Q1 smpr Debt Conversion Converted Instrument Interest
DebtConversionConvertedInstrumentInterest
18559 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
Standard Metals Processing, Inc.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000773717
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Public Float
EntityPublicFloat
69340936 USD
CY2014 dei Trading Symbol
TradingSymbol
SMPR
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103760936 shares
CY2014Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2500000 USD
CY2014Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000 shares
CY2013Q4 smpr Debt Conversion Converted Instrument Interest
DebtConversionConvertedInstrumentInterest
1997 USD
CY2013Q4 smpr Debt Conversion Converted Instrument Interest
DebtConversionConvertedInstrumentInterest
3732 USD
CY2014Q3 smpr Loss On Settlement Of Debt
LossOnSettlementOfDebt
147468 USD
CY2014Q3 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
2.00
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
118000 shares
CY2014 smpr Non Cash Gain Loss On Extinguishment Of Debt
NonCashGainLossOnExtinguishmentOfDebt
8206286 USD
CY2013 smpr Non Cash Gain Loss On Extinguishment Of Debt
NonCashGainLossOnExtinguishmentOfDebt
4107806 USD
CY2013Q4 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
1933345 USD
CY2014Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
275000 USD
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
275000 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
147468 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
CY2014 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Reclassification</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> Certain accounts in the prior period were reclassified to conform to the current period financial statements presentation.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name View Source Status
0001144204-15-020231-index-headers.html Edgar Link pending
0001144204-15-020231-index.html Edgar Link pending
0001144204-15-020231.txt Edgar Link pending
0001144204-15-020231-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smpr-20141231.xml Edgar Link completed
smpr-20141231.xsd Edgar Link pending
smpr-20141231_cal.xml Edgar Link unprocessable
smpr-20141231_def.xml Edgar Link unprocessable
smpr-20141231_lab.xml Edgar Link unprocessable
smpr-20141231_pre.xml Edgar Link unprocessable
tpg7.jpg Edgar Link pending
v404838_10k.htm Edgar Link pending
v404838_ex23-1.htm Edgar Link pending
v404838_ex31-1.htm Edgar Link pending
v404838_ex31-2.htm Edgar Link pending
v404838_ex32-1.htm Edgar Link pending
v404838_ex32-2.htm Edgar Link pending